TME Pharma N.V.'s total assets for Q2 2024 were €2.94M, an increase of 18.11% from the previous quarter. DE:0N6A total liabilities were €1.38M for the fiscal quarter, a -50.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.